Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study

por Lobna A. Abdelaziz, Heba F. Taha, Magid M. Ali, Marwa I. Abdelgawad, Amira Elwan
Publicado 2021

Forkhead box M1 over-expression and dachshund homolog 1 down- -regulation as novel biomarkers for progression of endometrial carcinoma in Egyptian patients

por Abeer M. Hafez, Ola Harb, Waleed M. Etman, Basem Hamed, Alfred E Namour, Lobna A. Abdelaziz
Publicado 2021